Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis

• Status: Completed
• Trial end date: 2015-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Dose response curve to define the security and tolerable dose to be used for prevention and treatment of radiodermatitis in patients with breast or head and neck cancer.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Brasilia
• Collaborator: University of Washington
• Treatments: Carbamide Peroxide

Criteria

Inclusion Criteria:

• Being an adult, over the age of 18 years old

• Owning diagnosis of breast or head and neck cancer

• Being first referred to the radiotherapy protocol

• Have absence of radiodermatitis and integrates skin to start radiotherapy

• Not have presented anticipated reaction of hypersensitivity to chamomile or any plant of the family Asteraceae or Compositae or urea.

• Demonstrate conditions to continue the intervention in their home environment when needed.

Exclusion Criteria:

• Medical prescription for the procedure of data collection, some kind of intervention to prevent radiodermatitis.